Thomas Jackson
Impact in
-
- Cancer Genomics and Diagnostics
Papers in
-
- Protein Degradation and Inhibitors 3
- RNA Interference and Gene Delivery 3
- Pluripotent Stem Cells Research 2
- Histone Deacetylase Inhibitors Research 2
-
- Acute Myeloid Leukemia Research 4
- Co-authors
- Paul A. Townsend (8 shared papers)Kristīne Salmiņa (4 shared papers)Anda Huna (4 shared papers)Jekaterina Ērenpreisa (4 shared papers)Mark S. Cragg (4 shared papers)Alejandro Vázquez‐Martín (2 shared papers)Anindita Roy (5 shared papers)Inna Inashkina (3 shared papers)
- Journals
- Blood (3 papers)Cell Cycle (3 papers)Oncotarget (2 papers)European Journal of Medicinal Chemistry (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- United KingdomUnited StatesLatvia
In The Last Decade
Thomas Jackson
22 papers receiving 453 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 76
- Aging 8
- Hematology 43
- Molecular Biology 253
- Cell Biology 59
Countries citing papers authored by Thomas Jackson
This map shows the geographic impact of Thomas Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Jackson more than expected).
Fields of papers citing papers by Thomas Jackson
This network shows the impact of papers produced by Thomas Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Jackson. The network helps show where Thomas Jackson may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Jackson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 71 | |
| 2 | 2015 | 55 | |
| 3 | 2017 | 45 | |
| 4 | 2016 | 44 | |
| 5 | 2008 | 40 | |
| 6 | 2013 | 39 | |
| 7 | 2021 | 29 | |
| 8 | 2015 | 28 | |
| 9 | 2020 | 22 | |
| 10 | 2021 | 21 | |
| 11 | 2019 | 16 | |
| 12 | 2018 | 15 | |
| 13 | 2015 | 11 | |
| 14 | 2015 | 10 | |
| 15 | 2024 | 5 | |
| 16 | 2023 | 5 | |
| 17 | 2021 | 5 | |
| 18 | 2016 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2024 | 1 |
About Thomas Jackson
Thomas Jackson is a scholar working on Molecular Biology, Hematology, Public Health, Environmental and Occupational Health, Cancer Research and Pediatrics, Perinatology and Child Health, having authored 23 papers that have together received 467 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Protein Degradation and Inhibitors (3 papers), RNA Interference and Gene Delivery (3 papers), Cancer Genomics and Diagnostics (2 papers), Pluripotent Stem Cells Research (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Prenatal Screening and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (76 citations), Aging (8 citations), Hematology (43 citations), Molecular Biology (253 citations) and Cell Biology (59 citations). Thomas Jackson has collaborated with scholars based in United Kingdom, United States and Latvia. Frequent co-authors include Paul A. Townsend, Kristīne Salmiņa, Anda Huna, Jekaterina Ērenpreisa, Mark S. Cragg, Alejandro Vázquez‐Martín, Anindita Roy, Inna Inashkina, Rebecca E. Ling and Anthony Howell. Their work appears in journals such as Blood, Cell Cycle, Oncotarget, European Journal of Medicinal Chemistry and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.